Surgical approach and outcomes in patients with lithium-associated hyperparathyroidism

Annals of Surgical Oncology

Volumn 19, Issue 11, 2012, Pages 3465-3471

  Marti, Jennifer L ^a,c   Yang, Catherine S ^a   Carling, Tobias ^a   Roman, Sanziana A ^a   Sosa, Julie A ^a   Donovan, Patricia ^a   Guoth, Maria S ^a   Heller, Keith S ^b   Udelsman, Robert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LITHIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPARATHYROIDISM; INTRAOPERATIVE PERIOD; MAJOR DEPRESSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOCYTOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RECURRENT DISEASE; SURGICAL APPROACH; THYROID ADENOMA; THYROID HYPERPLASIA; THYROID WEIGHT; THYROIDECTOMY; TREATMENT DURATION; TREATMENT OUTCOME;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; HYPERPLASIA; LITHIUM; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; ORGAN SIZE; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84868201662     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2367-6     Document Type: Article

References (26)

1. Chiu CT, Chuang DM. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther. 2010;128:281-304.
2. Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949;2:349-52.
3. Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: A metaanalytic review. Bipolar Disord. 2006;8:625-39. (Pubitemid 44567144)
4. Tondo L, Jamison KR, Baldessarini RJ. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci. 1997;836:339-51. (Pubitemid 28044034)
5. Dalan R, Leow MK, Jong M. Multiple endocrinopathies associated with lithium therapy. Endocr Pract. 2007;13:758-63.
6. Davis BM, Pfefferbaum A, Krutzik S, Davis KL. Lithium's effect of parathyroid hormone. Am J Psychiatry. 1981;138:489-92.
7. Christiansen C, Baastrup PC, Transbol I. Development of ''primary'' hyperparathyroidism during lithium therapy: Longitudinal study. Neuropsychobiology. 1980;6:280-3. (Pubitemid 10076893)
8. Livingstone C, Rampes H. Lithium: A review of its metabolic adverse effects. J Psychopharmacol. 2006;20:347-55.
9. Nordenstrom J, Elvius M, Bagedahl-Strindlund M, et al. Biochemical hyperparathyroidism and bone mineral status in patients treated long-term with lithium. Metabolism. 1994;43:1563-7.
10. Bendz H, Sjodin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy - a cross-sectional study and the effect of lithium withdrawal. J Intern Med. 1996;240:357-65.
11. Awad SS, Miskulin J, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg. 2003;27:486-8. (Pubitemid 36920127)
12. Kallner G, Lindelius R, Markiewicz P, et al. Hypercalcemia in lithium therapy - an underestimated complication? Lakartidningen. 1992;89:4163-4.
13. Stancer HC, Forbath N. Hyperparathyroidism, hypothyroidism, and impaired renal function after 10 to 20 years of lithium treatment. Arch Intern Med. 1989;149:1042-5. (Pubitemid 19131828)
14. Seely EW, Moore TJ, LeBoff MS, Brown EM. A single dose of lithium carbonate acutely elevates intact parathyroid hormone levels in humans. Acta Endocrinol (Cph). 1989;121:174-6. (Pubitemid 19212158)
15. Brown EM. Lithium induces abnormal calcium-regulated PTH release in dispersed bovine parathyroid cells. J Clin Endocrinol Metab. 1981;52:1046-8. (Pubitemid 13237501)
16. Mallette LE, Khouri K, Zengotita H, et al. Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab. 1989;68:654-60. (Pubitemid 19081443)
17. Haden ST, Stoll AL, McCormick S, et al. Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab. 1997;82:2844-8. (Pubitemid 27385637)
18. Meltzer HL. Lithium mechanisms in bipolar illness and altered intracellular calcium functions. Biol Psychiatry. 1986;21:492-510. (Pubitemid 16043747)
19. Levine J, Chengappa KN, Brar JS, et al. Psychotropic drug prescription patterns among patients with bipolar I disorder. Bipolar Disord. 2000;2:120-30.
20. Jarhult J, Ander S, Asking B, et al. Long-term results of surgery for lithium-associated hyperparathyroidism. Br J Surg. 2010;97:1680-5.
21. Carchman E, Ogilvie J, Holst J, et al. Appropriate surgical treatment of lithium-associated hyperparathyroidism. World J Surg. 2008;32:2195-9.
22. McHenry CR, Rosen IB, Rotstein LE, et al. Lithiumogenic disorders of the thyroid and parathyroid glands as surgical disease. Surgery. 1990;108:1001-5.
23. Kandil E, Dackiw AP, Alabbas H, et al. A profile of patients with hyperparathyroidism undergoing lithium therapy for affective psychiatric disorders. Head Neck. 2011;33:925-7.
24. Szalat A, Mazeh H, Freund HR. Lithium-associated hyperparathyroidism: Report of four cases and review of the literature. Eur J Endocrinol. 2009;160:317-23.
25. Hundley JC, Woodrum DT, Saunders BD, et al. Revisiting lithium- associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery. 2005;138:1027-31.
26. Abdullah H, Bliss R, Guinea AI, Delbridge L. Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg. 1999;86:91-3. (Pubitemid 29051915)